BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 29463395)

  • 21. Diabetic Kidney Disease.
    Tong L; Adler SG
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):335-338. PubMed ID: 29046291
    [No Abstract]   [Full Text] [Related]  

  • 22. Abysmal prognosis of patients with type 2 diabetes entering dialysis.
    Chantrel F; Enache I; Bouiller M; Kolb I; Kunz K; Petitjean P; Moulin B; Hannedouche T
    Nephrol Dial Transplant; 1999 Jan; 14(1):129-36. PubMed ID: 10052492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of renin-angiotensin system (RAS) blockers on cardiovascular and renal outcomes in patients with type 2 diabetes.
    Cao Z; Cooper ME
    Acta Diabetol; 2012 Aug; 49(4):243-54. PubMed ID: 21947383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of dyslipidemias in patients with diabetes and chronic kidney disease.
    Molitch ME
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1090-9. PubMed ID: 17699330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium-glucose cotransporter 2 inhibition in type 1 diabetes: simultaneous glucose lowering and renal protection?
    Cherney DZ; Perkins BA
    Can J Diabetes; 2014 Oct; 38(5):356-63. PubMed ID: 25192954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
    Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Parving HH; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S;
    N Engl J Med; 2001 Sep; 345(12):861-9. PubMed ID: 11565518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic kidney disease: a report from an ADA Consensus Conference.
    Tuttle KR; Bakris GL; Bilous RW; Chiang JL; de Boer IH; Goldstein-Fuchs J; Hirsch IB; Kalantar-Zadeh K; Narva AS; Navaneethan SD; Neumiller JJ; Patel UD; Ratner RE; Whaley-Connell AT; Molitch ME
    Am J Kidney Dis; 2014 Oct; 64(4):510-33. PubMed ID: 25257325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacoeconomic challenges in the management of diabetic nephropathy.
    Rodby RA
    J Manag Care Pharm; 2004 Sep; 10(5 Suppl A):S6-11. PubMed ID: 15369419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy.
    van der Sande NG; Dorresteijn JA; Visseren FL; Dwyer JP; Blankestijn PJ; van der Graaf Y; Heerspink HL
    Diabetes Obes Metab; 2016 Nov; 18(11):1120-1127. PubMed ID: 27337598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and treatment by the primary care provider of common diabetes complications.
    Gilbert MP
    Med Clin North Am; 2015 Jan; 99(1):201-19. PubMed ID: 25456651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes mellitus and dialysis.
    Stein G; Fünfstück R; Schiel R
    Minerva Urol Nefrol; 2004 Sep; 56(3):289-303. PubMed ID: 15467507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal complications of diabetes.
    Min TZ; Stephens MW; Kumar P; Chudleigh RA
    Br Med Bull; 2012; 104():113-27. PubMed ID: 23118262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Blood Pressure and Other Clinical Variables on Long-Term Mortality in a Cohort of Elderly Subjects with Type 2 Diabetes.
    Tessier DM; Meneilly GS; Moleski L; Trottier L; Lanthier L
    Can J Diabetes; 2016 Feb; 40(1):12-6. PubMed ID: 26827682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Barnett A
    Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodialysis in diabetic patients.
    Akmal M
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S195-9. PubMed ID: 11576954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.